Who are Ally Therapeutics's investors?

Ally Therapeutics's investors include Alta Partners, ARCH Venture Partners.

How much funding has Ally Therapeutics raised?

Ally Therapeutics has disclosed $10M raised across 1 round.

Ally Therapeutics is headquartered in Cambridge, US.

Cambridge, US · Founded 2018 · Delaware corporation · 2 known investors

Paths you didn't know you had: your email and LinkedIn already hold routes to the Ally Therapeutics team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Biotech addressing immune response issues that limit the safety and efficacy of in vivo gene therapies.

Tina LiuNamed on SEC filing

David CordoNamed on SEC filing

Erica WhittakerNamed on SEC filing

Steve GillisNamed on SEC filingManaging Director at ARCH Venture Partners

Bob MoreBoard directorManaging Director at Alta Partners

How we know: funding news · Not right? Tell us

Form D private placements

$10M disclosed across 1 round · 2019

▶$10MraisedAug 2019 · 3 investors · Pharmaceuticals

Rule 506(b)

Officers, directors & promoters on the filing

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

What does Ally Therapeutics do?: Biotech addressing immune response issues that limit the safety and efficacy of in vivo gene therapies.
Who are Ally Therapeutics's investors?: Ally Therapeutics's investors include Alta Partners, ARCH Venture Partners.
How much funding has Ally Therapeutics raised?: Ally Therapeutics has disclosed $10M raised across 1 round.
Where is Ally Therapeutics headquartered?: Ally Therapeutics is headquartered in Cambridge, US.